FindTrial
Sign In

AMG 714 Expanded Access Program

Status
NO_LONGER_AVAILABLE
Phases
Unknown
Study type
Expanded Access
Source
ClinicalTrials.gov
Registry ID
NCT03439475
Enrollment
Unknown
Registered
2018-02-20
Start date
Unknown
Completion date
Unknown
Last updated
2025-05-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Celiac Disease

Keywords

Refractory Celiac Disease Type II

Brief summary

Expanded access requests for AMG 714 may be considered for adult patients with biopsy proven Refractory Celiac Disease Type II who have failed all available treatment options and do not have EATL. To request access, use Responsible Party contact information provided in this record.

Interventions

BIOLOGICALAMG 714

Sponsors

Amgen
Lead SponsorINDUSTRY

Eligibility

Age
18 Years to No maximum

Inclusion criteria

\-

Exclusion criteria

\-

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026